Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Calcipotriol/Betamethasone Gel in Psoriasis Vulgaris
NCT00263718Phase 2Completed
- Sponsor
- LEO Pharma
- Start
- Dec 2005
- Modality
- Small Molecules
- Countries
- 5
01
Overview
Phase 2, randomised, double-blind trial of calcipotriol + betamethasone in Psoriasis vulgaris (PV) (4 arms), sponsored by LEO Pharma. Primary endpoint: Patients with controlled disease according to the investigators' global assessment at 8 weeks. Started Dec 2005; status: completed.
02
Drugs
calcipotriol + betamethasone
03
Conditions
Psoriasis vulgaris (PV)
Beyond the preview
Go deeper on NCT00263718.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00263718.